Top Markets
#1 ADO Protocol ADO Protocol +196.06%
#2 Islamic Coin Islamic Coin +155.47%
#3 GoPlus Security GoPlus Security +56.58%
#4 Starpower Starpower +26.15%
#5 GAIB AID GAIB AID +24.67%
#6 Casper Network Casper Network +17.22%
#7 The Black Bull The Black Bull +14.25%
#8 Verus Coin Verus Coin +13.53%
#9 Pons Pons +11.95%
#10 Zano Zano +11.94%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rank in Stocks #33327
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer’s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Share Price
$0.12476927
Last synced: 2026-08-14
Market Cap
$7.86M
Change (1 day)
6.25%
Change (1 year)
-19.80%
Country
CA
Trade Marvel Biosciences Corp. (MRVL)

Category

Healthcare
Earnings for Marvel Biosciences Corp. (MRVL)
Earnings in 2026 TTM: 0
According to Marvel Biosciences Corp. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Marvel Biosciences Corp. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE